← Fermented Foods

Sauerkraut

How lacto-fermented cabbage feeds your gut microbiome, reduces inflammation, and delivers bioactive compounds that support long-term health

Sauerkraut is finely shredded cabbage fermented by naturally occurring lactic acid bacteria — no vinegar, no heat, no additives needed. The fermentation process unlocks nutrients that are locked inside raw cabbage, produces billions of beneficial microbes, and generates short-chain fatty acids that nourish the gut lining [1]. It is one of the oldest preserved foods in the world, and modern research confirms that regular consumption meaningfully supports the gut microbiome, reduces digestive symptoms, and delivers bioactive plant compounds linked to long-term health [2][3].

How Fermentation Transforms Cabbage

Raw cabbage is already nutritious — it contains fiber, vitamin C, vitamin K, and glucosinolates, the sulfur compounds that give brassicas their characteristic smell. But lacto-fermentation changes cabbage in several important ways.

When shredded cabbage is packed with salt, naturally present bacteria — primarily Lactiplantibacillus plantarum, Leuconostoc mesenteroides, and Pediococcus species — begin consuming the cabbage's natural sugars and producing lactic acid. This acidic environment acts as a natural preservative while simultaneously:

  • Breaking glucosinolates into isothiocyanates (including indole-3-carbinol and ascorbigen), which are more bioavailable and biologically active than the precursor compounds [5]
  • Generating lactic acid, which feeds colonocytes and supports a healthy gut pH
  • Producing short-chain fatty acids (SCFAs), particularly after the fermented food reaches the colon [1]
  • Increasing the bioavailability of vitamin C and other nutrients by reducing anti-nutritional compounds

A one-cup serving provides roughly 35% of daily vitamin C, 25% of vitamin K, 4 grams of fiber, and only 32 calories — all in a more bioavailable form than raw cabbage.

Gut Microbiome and Digestive Benefits

A 2025 crossover trial with 87 healthy adults found that four weeks of daily sauerkraut consumption (both fresh and pasteurized) produced measurable changes in gut microbial species composition, detected by shotgun metagenomic sequencing [1]. Pasteurized sauerkraut notably increased serum short-chain fatty acids, suggesting the fermented matrix itself — not just live bacteria — carries gut-supporting compounds.

For people with irritable bowel syndrome (IBS), a pilot trial found that 75 grams of sauerkraut daily for six weeks significantly reduced IBS Severity Scoring System scores in both pasteurized and unpasteurized groups, with mean IBS-SSS reductions of 39–57 points [2]. The unpasteurized group showed increased L. plantarum and L. brevis colonization in stool samples.

Fresh vs. Pasteurized

Fresh, unpasteurized sauerkraut contains live bacteria. Pasteurized sauerkraut has no live cultures but still contains fermented metabolites — lactic acid, bioactive peptides, SCFAs, and transformed glucosinolates. Both forms appear to offer health benefits through different mechanisms.

Look for sauerkraut in the refrigerated section with no vinegar in the ingredients. Traditional preparation requires only cabbage and salt.

Making Your Own

Homemade sauerkraut is straightforward:

  • Shred cabbage, mix with 2% salt by weight
  • Pack tightly into a jar, pressing until brine rises above the cabbage
  • Cover and ferment at room temperature for 5–14 days
  • Move to the refrigerator once the flavor is pleasantly sour

See our fermented foods overview for more on how lacto-fermentation works and which other fermented foods support gut health.

Evidence Review

Gut Microbiome Studies

The strongest direct evidence for sauerkraut's impact on gut health comes from a 2025 German crossover trial (PMID 39940045) — 87 healthy adults consumed either fresh or pasteurized sauerkraut daily for four weeks, with shotgun metagenomic sequencing used to assess gut microbiome changes before and after each intervention. Both interventions produced measurable shifts in specific bacterial species, with pasteurized sauerkraut showing more pronounced changes and a significant increase in serum short-chain fatty acids. The authors noted that the healthy gut microbiome is "relatively resilient" to short-term dietary shifts, suggesting longer-term or higher-dose intake may produce larger effects.

A 2018 pilot RCT (PMID 30256365, n=34 IBS patients) randomized participants to pasteurized or unpasteurized sauerkraut (75g/day for 6 weeks). Both groups showed significant improvement in IBS-SSS scores (pasteurized: -39 ± 17 points; unpasteurized: -57 ± 17 points; both p < 0.04). Unpasteurized sauerkraut increased detectable L. plantarum and L. brevis in the gut, confirming live bacterial transfer, though both forms reduced symptom severity. This study is limited by its small sample size and lack of a placebo group, but the magnitude of symptom improvement is clinically meaningful.

Broader Literature Overview

A bibliometric analysis (PMID 25568828) reviewed 139 publications on sauerkraut spanning 1921–2012 and found that the majority of human studies focused on digestive health, with consistent evidence supporting probiotic and prebiotic effects. The review identified important caveats: sauerkraut's high tyramine content can interact with monoamine oxidase inhibitors (MAOIs), and excessive intake may cause loose stools in sensitive individuals. For most people, 50–75g per day is well tolerated.

Cancer Risk Reduction

Epidemiological evidence connects high cabbage and sauerkraut intake to reduced breast cancer risk. A case-control study among Polish migrant women in the United States (PMID 34682540, 131 breast cancer cases, 284 controls) found that women who consumed three or more servings of raw/lightly cooked cabbage or sauerkraut per week during adolescence had significantly lower breast cancer risk than those eating one serving per week or less. The protective association persisted into adulthood.

The proposed mechanism involves isothiocyanates — bioactive compounds derived from glucosinolate hydrolysis that are particularly abundant in fermented cabbage [5]. A 2023 review (PMID 37921869) summarized mechanisms including induction of Nrf2-mediated detoxification, inhibition of NF-κB inflammatory signaling, upregulation of apoptosis through caspase pathways, and epigenetic modulation of tumor suppressor genes. Fermentation may enhance glucosinolate bioavailability compared to cooked cabbage, though evidence comparing sauerkraut to fresh cabbage directly in human trials remains limited.

Strength of Evidence

The IBS and gut microbiome evidence is moderate — RCTs exist but are small, and effects in healthy populations appear modest over short timeframes. The cancer prevention data is observational and cannot prove causation. The mechanistic plausibility is strong, supported by in vitro and animal data, but large-scale intervention trials specifically for sauerkraut in cancer prevention have not been conducted. Overall, sauerkraut is a well-tolerated, nutrient-dense food with genuine mechanistic support and encouraging early clinical evidence — particularly for those with IBS or interest in supporting gut microbiome diversity.

References

  1. The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trialSchropp N, et al.. Microbiome, 2025. PubMed 39940045 →
  2. Lacto-fermented sauerkraut improves symptoms in IBS patients independent of product pasteurisation - a pilot studyNielsen ES, et al.. Food & Function, 2018. PubMed 30256365 →
  3. Regular consumption of sauerkraut and its effect on human health: a bibliometric analysisRaak C, Ostermann T, Boehm K, Molsberger F. Global Advances in Health and Medicine, 2014. PubMed 25568828 →
  4. Cabbage and Sauerkraut Consumption in Adolescence and Adulthood and Breast Cancer Risk among US-Resident Polish Migrant WomenPathak DR, et al.. International Journal of Environmental Research and Public Health, 2021. PubMed 34682540 →
  5. Glucosinolates in cancer prevention and treatment: experimental and clinical evidenceOrouji N, Asl SK, Taghipour Z, et al.. Medical Oncology, 2023. PubMed 37921869 →

Weekly Research Digest

Get new topics and updated research delivered to your inbox.